Literature DB >> 29115714

Deep vein thrombosis in pediatric patients.

Julie Jaffray1, Guy Young1.   

Abstract

Due to advances in caring for critically ill children and those with chronic diseases, rates of deep vein thrombosis (DVT) are increasing in children. Risk factors consist of central venous catheters, chronic medical conditions, thrombophilia, and various medications. Compression Doppler ultrasonography is the method most commonly used to diagnose DVT, and patients will usually present with pain and swelling of the affected limb. Anticoagulation via subcutaneous injection is the most common treatment regime for children with DVT, and the new, direct oral anticoagulants are currently under investigation. Prevention techniques are not established, but clinical studies are addressing this need.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anticoagulation therapy; coagulation thrombolytic; hematology hemostasis and thrombosis; thrombophilia; thrombosis; thrombotic disorders

Mesh:

Substances:

Year:  2017        PMID: 29115714     DOI: 10.1002/pbc.26881

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Thrombosis and Anticoagulant Therapy Among Pediatric Cancer Patients: Real-Life Data.

Authors:  Hasan Hashem; Momen Zeineddin; Rayan Bater; Nisreen Amayiri; Wiam Al Qasem; Bilasan Hammo; Iyad Sultan; Rama AlMasri; Hikmat Abdel-Razeq
Journal:  Cureus       Date:  2021-12-01

2.  Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill children.

Authors:  Åsa K M Östlund; Urban Fläring; Peter Larsson; Sylvie Kaiser; Lena Vermin; Tony Frisk; Ann Dahlberg; Jonas Berner; Åke Norberg; Andreas Andersson
Journal:  Eur J Pediatr       Date:  2022-06-02       Impact factor: 3.860

3.  Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium.

Authors:  Elizabeth T Stephens; Anh Thy H Nguyen; Julie Jaffray; Brian Branchford; Ernest K Amankwah; Neil A Goldenberg; E Vincent S Faustino; Neil A Zakai; Amy Stillings; Emily Krava; Guy Young; John H Fargo
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13

4.  The role of valve stiffness in the insurgence of deep vein thrombosis.

Authors:  Zoe Schofield; Hosam Alden Baksamawi; Joana Campos; Alessio Alexiadis; Gerard B Nash; Alexander Brill; Daniele Vigolo
Journal:  Commun Mater       Date:  2020-09-16

5.  The Correlation Between FGB Promoter Polymorphism and Clotting Function in Patients With Idiopathic Lower Extremity Deep Venous Thrombosis.

Authors:  Shengbin Han; Bin Yang; Yaoyu Feng; Lingfeng Zhao; Qun Feng; Hongxi Guan; Donghui Song; Fang Yin; Li Zhuang
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  Effect of Clinical Nursing Pathway Intervention Based on Evidence-Based Medicine on Venous Thrombosis in Long-Term Bedridden Patients.

Authors:  Jing Chen; Yanli Wen; Lin Jin; Junwei Peng; Jin Ji
Journal:  J Healthc Eng       Date:  2022-03-14       Impact factor: 2.682

Review 7.  Immune Factors in Deep Vein Thrombosis Initiation.

Authors:  Ivan Budnik; Alexander Brill
Journal:  Trends Immunol       Date:  2018-05-16       Impact factor: 16.687

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.